Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Inflammatory Characteristics of Symptomatic Glioma Associated With Poor Prognosis and Chemoresistance via Tumor Necrosis Factor Signaling Pathway.

Brain tumor research and treatment·2024
Same author

Comparing the Expression of Canonical and Non-Canonical Inflammasomes Across Glioma Grades: Evaluating Their Potential as an Aggressiveness Marker.

Brain tumor research and treatment·2023
Same author

Cerebral Microangiopathy Mimicking a High-Grade Glioma in Old Age: A Case Report.

Brain tumor research and treatment·2022
Same author

Intracranial aspergillosis in immunocompetent adult patients without risk factors: a systematic review.

Neurosurgical review·2022
Same author

Influence of the Amount of Fresh Specimen on the Isolation of Tumor Mesenchymal Stem-Like Cells from High-Grade Glioma.

Yonsei medical journal·2021
Same author

Autologous adoptive immune-cell therapy elicited a durable response with enhanced immune reaction signatures in patients with recurrent glioblastoma: An open label, phase I/IIa trial.

PloS one·2021

Related Experiment Video

Updated: Jul 4, 2025

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells
10:01

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Published on: August 2, 2022

6.5K

Clinical Practice Guidelines for Brain Metastasis From Solid Tumors.

Kyoung Su Sung1

  • 1Department of Neurosurgery, Dong-A University Hospital, Dong-A University College of Medicine, Busan, Korea. sungks1465@gmail.com.

Brain Tumor Research and Treatment
|February 6, 2024
PubMed
Summary

Updated clinical practice guidelines for brain metastases (BMs) are crucial due to increased diagnoses. This review summarizes recent ASCO-SNO-ASTRO and EANO-ESMO guidelines for managing BMs from solid tumors.

Keywords:
Brain metastasesBrain tumorMalignant brain neoplasm

More Related Videos

Modeling Brain Metastases Through Intracranial Injection and Magnetic Resonance Imaging
06:44

Modeling Brain Metastases Through Intracranial Injection and Magnetic Resonance Imaging

Published on: June 7, 2020

7.3K
Intracarotid Cancer Cell Injection to Produce Mouse Models of Brain Metastasis
07:43

Intracarotid Cancer Cell Injection to Produce Mouse Models of Brain Metastasis

Published on: February 8, 2017

26.7K

Related Experiment Videos

Last Updated: Jul 4, 2025

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells
10:01

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Published on: August 2, 2022

6.5K
Modeling Brain Metastases Through Intracranial Injection and Magnetic Resonance Imaging
06:44

Modeling Brain Metastases Through Intracranial Injection and Magnetic Resonance Imaging

Published on: June 7, 2020

7.3K
Intracarotid Cancer Cell Injection to Produce Mouse Models of Brain Metastasis
07:43

Intracarotid Cancer Cell Injection to Produce Mouse Models of Brain Metastasis

Published on: February 8, 2017

26.7K

Area of Science:

  • Oncology
  • Neurology
  • Clinical Practice Guidelines

Background:

  • Advancements in systemic cancer therapies have led to increased incidence and diagnosis of brain metastases (BMs).
  • Developments in neurosurgery, radiotherapy, and systemic therapies (immune and targeted) for BMs necessitate updated clinical guidance.
  • Recent clinical practice guidelines for BMs from solid tumors have been published by ASCO-SNO-ASTRO and EANO-ESMO.

Purpose of the Study:

  • To provide an overview of the recent clinical practice guidelines for brain metastases (BMs) from solid tumors.
  • To synthesize recommendations from the ASCO-SNO-ASTRO and EANO-ESMO guidelines.
  • To highlight key aspects of diagnosis, therapy, and follow-up for BMs.

Main Methods:

  • Systematic literature review and expert panel evaluation (ASCO-SNO-ASTRO guidelines).
  • Selection of relevant literature by expert authors, confirmed by consensus (EANO-ESMO guidelines).
  • Focus on summarizing recommendations for surgery, radiotherapy, systemic therapy, prevention, diagnosis, and follow-up.

Main Results:

  • The ASCO-SNO-ASTRO guidelines (2021) address key therapeutic questions for BMs.
  • The EANO-ESMO guidelines (2021) cover prevention, diagnosis, therapy, and follow-up for BMs.
  • Both guidelines represent recent expert consensus on managing BMs from solid tumors.

Conclusions:

  • Updated clinical practice guidelines are essential for managing the rising incidence of brain metastases.
  • The ASCO-SNO-ASTRO and EANO-ESMO guidelines offer comprehensive, evidence-based recommendations for BM care.
  • These guidelines will inform clinical decision-making and improve outcomes for patients with BMs.